Ledyard National Bank Sells 31 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ledyard National Bank lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the fourth quarter, HoldingsChannel reports. The firm owned 404 shares of the medical equipment provider’s stock after selling 31 shares during the quarter. Ledyard National Bank’s holdings in Intuitive Surgical were worth $211,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ISRG. Silver Oak Securities Incorporated raised its position in Intuitive Surgical by 12.8% during the fourth quarter. Silver Oak Securities Incorporated now owns 1,784 shares of the medical equipment provider’s stock worth $940,000 after acquiring an additional 203 shares in the last quarter. Legacy CG LLC increased its stake in shares of Intuitive Surgical by 28.1% during the 4th quarter. Legacy CG LLC now owns 8,479 shares of the medical equipment provider’s stock worth $4,426,000 after purchasing an additional 1,861 shares during the last quarter. YANKCOM Partnership bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $441,000. Bleakley Financial Group LLC lifted its stake in Intuitive Surgical by 12.6% in the 4th quarter. Bleakley Financial Group LLC now owns 9,433 shares of the medical equipment provider’s stock valued at $4,923,000 after purchasing an additional 1,055 shares during the last quarter. Finally, Kercheville Advisors LLC grew its holdings in Intuitive Surgical by 25.1% during the fourth quarter. Kercheville Advisors LLC now owns 1,070 shares of the medical equipment provider’s stock worth $558,000 after purchasing an additional 215 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,940 shares of company stock valued at $3,333,485 over the last quarter. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 0.9 %

Shares of ISRG stock opened at $582.98 on Friday. The firm has a market capitalization of $207.65 billion, a P/E ratio of 90.95, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock’s fifty day simple moving average is $554.03 and its 200 day simple moving average is $513.12.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Wells Fargo & Company raised their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Mizuho increased their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Truist Financial lifted their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.